☰

Megan N. Thobe, Ph.D. - Publications

Affiliations: 
2010 Cell & Molecular Biology University of Cincinnati, Cincinnati, OH 
Area:
Molecular Biology, Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Knopeke MT, Ritschdorff ET, Clark R, Vander Griend DJ, Khan S, Thobe M, Shear JB, Rinker-Schaeffer CW. Building on the foundation of daring hypotheses: using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization. Febs Letters. 585: 3159-65. PMID 21925502 DOI: 10.1016/J.Febslet.2011.09.007  0.48
2011 Thobe MN, Gray JK, Gurusamy D, Paluch AM, Wagh PK, Pathrose P, Lentsch AB, Waltz SE. The Ron receptor promotes prostate tumor growth in the TRAMP mouse model. Oncogene. 30: 4990-8. PMID 21625214 DOI: 10.1038/Onc.2011.205  0.653
2011 Thobe MN, Clark RJ, Bainer RO, Prasad SM, Rinker-Schaeffer CW. From prostate to bone: key players in prostate cancer bone metastasis. Cancers. 3: 478-93. PMID 21603150 DOI: 10.3390/Cancers3010478  0.476
2011 Paluch AM, Thobe MN, Gray JK, Gurusamy D, Waltz SE. Abstract A13: Lineage-specific roles for the Ron receptor in prostate cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-A13  0.577
2010 Thobe MN, Gurusamy D, Pathrose P, Waltz SE. The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells. Oncogene. 29: 214-26. PMID 19838218 DOI: 10.1038/Onc.2009.331  0.691
2007 Leonis MA, Thobe MN, Waltz SE. Ron-receptor tyrosine kinase in tumorigenesis and metastasis. Future Oncology (London, England). 3: 441-8. PMID 17661719 DOI: 10.2217/14796694.3.4.441  0.732
2006 Zinser GM, Leonis MA, Toney K, Pathrose P, Thobe M, Kader SA, Peace BE, Beauman SR, Collins MH, Waltz SE. Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation. Cancer Research. 66: 11967-74. PMID 17178895 DOI: 10.1158/0008-5472.Can-06-2473  0.469
2006 O'Toole JM, Rabenau KE, Burns K, Lu D, Mangalampalli V, Balderes P, Covino N, Bassi R, Prewett M, Gottfredsen KJ, Thobe MN, Cheng Y, Li Y, Hicklin DJ, Zhu Z, et al. Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member. Cancer Research. 66: 9162-70. PMID 16982759 DOI: 10.1158/0008-5472.Can-06-0283  0.699
2005 Wise-Draper TM, Allen HV, Thobe MN, Jones EE, Habash KB, Münger K, Wells SI. The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7. Journal of Virology. 79: 14309-17. PMID 16254365 DOI: 10.1128/Jvi.79.22.14309-14317.2005  0.333
Show low-probability matches.